Last quarter (Q3 2025), ATAI Life Sciences's total revenue was $749.00K, a decrease of -15080.00% from the same quarter last year. In Q3, ATAI Life Sciences's net income was $-61.07M. See ATAI Life Sciences’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Total Revenue	$ 308.00K	$ 314.00K	$ 233.00K	$ 20.38M	$ 0.00
Gross Profit	$ 308.00K	$ 314.00K	$ 233.00K	$ 20.38M	$ 0.00
Operating Expenses	$ 103.00M	$ 125.78M	$ 145.02M	$ 156.18M	$ 104.16M
Depreciation and Amortization	$ 473.00K	$ 319.00K	$ 168.00K	$ 47.00K	$ 24.00K
EBITDA	$ -144.81M	$ -36.31M	$ -134.09M	$ -120.28M	$ -92.12M
Operating Income	$ -102.69M	$ -125.47M	$ -144.79M	$ -135.81M	$ -104.16M
Other Income/Expenses	$ -47.71M	$ 82.59M	$ -6.40M	$ -42.43M	$ -74.16M
Pretax Income	$ -150.41M	$ -42.88M	$ -151.19M	$ -178.23M	$ -178.32M
Net Income	$ -149.27M	$ -40.22M	$ -152.38M	$ -167.81M	$ -169.84M
Per Share Metrics
Basic EPS	$ -0.93	$ -0.25	$ -0.91	$ -0.83	$ -0.67
Diluted EPS	$ -0.93	$ -0.25	$ -0.91	$ -0.83	$ -0.67
Weighted Average Shares Outstanding	160.16M	158.83M	155.72M	160.68M	152.57M
Weighted Average Shares Outstanding (Diluted)	160.16M	158.83M	155.72M	160.68M	152.57M

Currency in USD

ATAI Life Sciences Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing